Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism?
Bonnar
J
J
Department of Obstetrics and Gynaecology, Trinity College, St James's Hospital, Dublin, 8, Ireland.
D000925:Anticoagulants / Q000627:therapeutic use; D002585:Cesarean Section / Q000009:adverse effects / Q000706:statistics & numerical data; D005260:Female; D006176:Gynecology / Q000379:methods; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009017:Morbidity; D009774:Obstetrics / Q000379:methods; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000209:etiology / Q000401:mortality* / Q000517:prevention & control; D012307:Risk Factors; D019851:Thrombophilia / Q000235:genetics; D020246:Venous Thrombosis / Q000235:genetics / Q000401:mortality* / Q000517:prevention & control
D000925:Anticoagulants; D006493:Heparin